KOK - MANAGER
Edit File: 1748962521.M365060P640782.premium12.web-hosting.com,S=9764,W=9893
Return-Path: <subscribe@authorankurjain.com> Delivered-To: info@authorankurjain.com Received: from premium12.web-hosting.com by premium12.web-hosting.com with LMTP id yH+KFNkMP2gOxwkAcMox/g (envelope-from <subscribe@authorankurjain.com>) for <info@authorankurjain.com>; Tue, 03 Jun 2025 10:55:21 -0400 Return-path: <subscribe@authorankurjain.com> Envelope-to: info@authorankurjain.com Delivery-date: Tue, 03 Jun 2025 10:55:21 -0400 Received: from [198.54.126.158] (port=36762 helo=www.authorankurjain.com) by premium12.web-hosting.com with esmtpsa (TLS1.3) tls TLS_AES_256_GCM_SHA384 (Exim 4.98.1) (envelope-from <subscribe@authorankurjain.com>) id 1uMT2u-00000002ico-3pK0 for info@authorankurjain.com; Tue, 03 Jun 2025 10:55:20 -0400 Date: Tue, 3 Jun 2025 14:55:20 +0000 To: info@authorankurjain.com From: =?UTF-8?B?0KjQo9CT0JDQoNCY0J3QkyAo0KHQsNGF0LDRgNC90LDRjyDQtNC10L/QuNC7?= =?UTF-8?B?0Y/RhtC40Y8pINCb0Y7QsdCw0Y8g0LHQvtC70LXQt9C90Ywg0YMg0YDQsNC3?= =?UTF-8?B?0L3Ri9GFINC70Y7QtNC10Lkg0L/RgNC+0Y/QstC70Y/QtdGC0YHRjyDQv9C+?= =?UTF-8?B?LdGA0LDQt9C90L7QvNGDIGh0dHBzOi8vYXl1cmRhcmEucnUvbg==?= =?UTF-8?B?YXNoaV9zcGVjaWFsaXN0eS9wc2lob2xvZ19zZXJn?= =?UTF-8?B?ZWpfemFncmViYWxfbnlqLzEzLyAg0KDQsNC30LvQuNGH0LjRjyA=?= =?UTF-8?B?0LrQsNGB0LDRjtGC0YHRjyDQvdC1INGC0L7Qu9GM0LrQviDQstC10LTRg9GJ?= =?UTF-8?B?0LjRhSDRgdC40LzQv9GC0L7QvNC+0LIg0LHQvtC70LXQt9C90LgsINC90L4g?= =?UTF-8?B?0YLQsNC60LbQtSwg0Lgg0LTQsNC20LUg0LIg0LHQvtC70YzRiNC10Lkg0YE=?= =?UTF-8?B?0YLQtdC/0LXQvdC4LCDRgtCw0LrQuNGFINC00LXRgtCw0LvQtdC5LCDQutCw?= =?UTF-8?B?0Log0LjQt9C80LXQvdC10L3QuNGPINC90LDRgdGC0YDQvtC10L3QuNGPLCA=?= =?UTF-8?B?0LbQsNC20LTQsCwg0LDQv9C/0LXRgtC40YIsINGA0LXQsNC60YbQuNGPINC9?= =?UTF-8?B?0LAg0YLQtdC80L/QtdGA0LDRgtGD0YDRgyDQuCDQtNGAIGh0dHBzOi8vYXl1?= =?UTF-8?B?cmRhcmEucnUvdXNsdWdpX2lfY2VueS9tZWRvdm8t?= =?UTF-8?B?dHZvcm96aG55al9za3JhYi8gINCn0YLQvtCx0Ysg0LPQvtC80LXQvg==?= =?UTF-8?B?0L/QsNGC0LjRh9C10YHQutC+0LUg0LvQtdC60LDRgNGB0YLQstC+INGB0YA=?= =?UTF-8?B?0LDQsdC+0YLQsNC70L4sINC+0L3QviDQtNC+0LvQttC90L4g0L/QvtC00LE=?= =?UTF-8?B?0LjRgNCw0YLRjNGB0Y8g0YEg0YPRh9GR0YLQvtC8INCy0YHQtdGFINGN0YI=?= =?UTF-8?B?0LjRhSDQuNC90LTQuNCy0LjQtNGD0LDQu9GM0L3Ri9GFINC/0YDQvtGP0LI=?= =?UTF-8?B?0LvQtdC90LjQuSBodHRwczovL2F5dXJkYXJhLnJ1L3ZvcHI=?= =?UTF-8?B?b3Mtb3R2ZXQvbXlfdl9rb250YWt0ZS8gINCf0L7RjdGC0L4=?= =?UTF-8?B?0LzRgyDQvdC1INGD0LTQuNCy0LvRj9C50YLQtdGB0YwsINC60L7Qs9C00LAg?= =?UTF-8?B?0L3QsCDQv9GA0LjQtdC80LUg0YMg0LPQvtC80LXQvtC/0LDRgtCwLCDQktCw?= =?UTF-8?B?0Lwg0LHRg9C00LXRgiDQt9Cw0LTQsNC90L4g0L7Qs9GA0L7QvNC90L7QtSA=?= =?UTF-8?B?0LrQvtC70LjRh9C10YHRgtCy0L4g0LLQvtC/0YDQvtGB0L7Qsiwg0LrQsNGB?= =?UTF-8?B?0LDRjtGJ0LjRhdGB0Y8g0JLQsNGI0LjRhSDQv9GA0LjRgdGC0YDQsNGB0YI=?= =?UTF-8?B?0LjQuSwg0L/RgNC40LLRi9GH0LXQuiDQuCDQvNC90L7Qs9C+0LPQviDQtNGA?= =?UTF-8?B?0YPQs9C+0LPQviwg0YfRgtC+INC90LAg0L/QtdGA0LLRi9C5INCy0LfQs9C7?= =?UTF-8?B?0Y/QtCDQutCw0LbQtdGC0YHRjyDQvdC10YHRg9GJ0LXRgdGC0LLQtdC90L0=?= =?UTF-8?B?0YvQvCBodHRwczovL2F5dXJkYXJhLnJ1L2ZvdG9hbF8=?= =?UTF-8?B?Ym9teS9zZW1pbmFyX2Rva3RvcmFfc25laGlfYmhh?= =?UTF-8?B?Z3ZhdF9wcm9ibGVteV96aGVuc2tvZ29femRvcm92?= =?UTF-8?B?X3lhX2lfcHV0aV9paF9lc3Rlc3R2ZW5ub2dvX3Jl?= =?UTF-8?B?c2hlbml5YS9fLyAg0J/RgNC4INGN0YLQvtC8INGB0LDQvCDQv9GA0LjQtdC8?= =?UTF-8?B?INC/0YDQvtC00LvQuNGC0YHRjyDQvdC10YHQutC+0LvRjNC60L4g0LTQvtC7?= =?UTF-8?B?0YzRiNC1INC+0LHRi9GH0L3QvtCz0L4gaHR0cHM6Ly9heXVyZGFyYS4=?= =?UTF-8?B?cnUvZm90b2FsX2JvbXkvZ29hLzEyLyBQYXJpdmFy?= =?UTF-8?B?IOKAlCDRjdGC0L4g0YHQtdC80YzRjyBodHRwczovL2F5dXJkYXJhLg==?= =?UTF-8?B?cnUvc3JlZHN0dmFfZmlybXlfa290dGFra2FsL3Nh?= =?UTF-8?B?aGFjaGFyYWRpX2thc2hheWFtLyDQkNC60YbQuNC4INC90LAg0Lw=?= =?UTF-8?B?0LDRgdGB0LDQttC4INC4INC/0YDQvtGG0LXQtNGD0YDRiyBodHRwczovL2F5?= =?UTF-8?B?dXJkYXJhLnJ1L2ZvdG9hbF9ib215L2luZGlqc2tp?= =?UTF-8?B?al90cmFkaWNpb25ueWpfY2VudHJfemRvcm92X3lh?= =?UTF-8?B?X2F5dXJkYXJhLzE0LyDQlNC10LnRgdGC0LLQuNC1INC70LXQutCw0YDRgdGC?= =?UTF-8?B?0LIg0L/QviDQv9GA0LjQvdGG0LjQv9GDINC/0L7QtNC+0LHQuNGPINGC0LU=?= =?UTF-8?B?0LwsINGH0YLQviDQs9C+0LzQtdC+0L/QsNGC0LjRh9C10YHQutC+0LUg0YE=?= =?UTF-8?B?0YDQtdC00YHRgtCy0L4sINCy0L3QvtGB0LjQvNC+0LUg0LIg0L7RgNCz0LA=?= =?UTF-8?B?0L3QuNC30LwsINCy0YvQt9GL0LLQsNC10YIg0YLQsNC8INGC0LDQuiDQvdCw?= =?UTF-8?B?0LfRi9Cy0LDQtdC80YPRjiDQu9C10LrQsNGA0YHRgtCy0LXQvdC90YPRjiA=?= =?UTF-8?B?0LHQvtC70LXQt9C90YwsINC60L7RgtC+0YDQsNGPINCy0YvRgtC10YHQvdC4?= =?UTF-8?B?0YIg0LjQtyDQvtGA0LPQsNC90LjQt9C80LAg0LHQvtC70LXQt9C90Ywg0LU=?= =?UTF-8?B?0YHRgtC10YHRgtCy0LXQvdC90YPRjiwg0L/RgNC4INGD0YHQu9C+0LLQuNC4?= =?UTF-8?B?LCDRh9GC0L4g0LvQtdC60LDRgNGB0YLQstC10L3QvdCw0Y8g0LHQvtC70LU=?= =?UTF-8?B?0LfQvdGMINCx0YPQtNC10YIg0LjQvNC10YLRjCDQtNC+0YHRgtCw0YLQvtGH?= =?UTF-8?B?0L3Rg9GOINGB0LjQu9GDIGh0dHBzOi8vYXl1cmRhcmEucnUvZg==?= =?UTF-8?B?b3RvYWxfYm9teS9kZW5fam9naV8yMDIxLyAg0KfQtdC8?= =?UTF-8?B?INCx0L7Qu9C10LUg0L/QvtC00L7QsdC90YvQvNC4INC+0LrQsNC20YPRgtGB?= =?UTF-8?B?0Y8g0YHQuNC80L/RgtC+0LzRiyDQu9C10LrQsNGA0YHRgtCy0LXQvdC90L4=?= =?UTF-8?B?0Lkg0LHQvtC70LXQt9C90Lgg0YHQuNC80L/RgtC+0LzQsNC8INC10YHRgtC1?= =?UTF-8?B?0YHRgtCy0LXQvdC90L7QuSwg0YLQtdC8INGB0LjQu9GM0L3QtdC1INCx0YM=?= =?UTF-8?B?0LTQtdGCIGh0dHBzOi8vYXl1cmRhcmEucnUvYXl1cnZl?= =?UTF-8?B?ZGljaGVza2llX3ByZXBhcmF0eV9oaW1hbGF5YV9o?= =?UTF-8?B?ZXJiYWxzX2luZGl5YS9rYXBpa2FjaGh1X2thcGlr?= =?UTF-8?B?YWNoaHVfaGltYWxheWEvINCR0LjQvtGA0LXQt9C+0L3QsNC90YHQvdCw0Y8=?= =?UTF-8?B?INCc0J7QoNCQLdGC0LXRgNCw0L/QuNGPIOKAkyDQvdC+0LLQtdC50YjQsNGP?= =?UTF-8?B?INGA0LDQt9GA0LDQsdC+0YLQutCwIE1FRC1UUk9OSUsgKNCT0LXRgNC80LA=?= =?UTF-8?B?0L3QuNGPIOKAkyDQu9C40LTQtdGAINCyINGB0L7Qt9C00LDQvdC40Lgg0L8=?= =?UTF-8?B?0YDQuNCx0L7RgNC+0LIg0LTQu9GPINCx0LjQvtGA0LXQt9C+0L3QsNC90YE=?= =?UTF-8?B?0L3QvtC5INGC0LXRgNCw0L/QuNC4KSwg0LLQutC70Y7Rh9Cw0Y7RidCw0Y8g?= =?UTF-8?B?0LIg0YHQtdCx0Y8g0YHQuNC90YLQtdC3INGB0L7QstGA0LXQvNC10L3QvdGL?= =?UTF-8?B?0YUg0LTQvtGB0YLQuNC20LXQvdC40Lkg0Y3QvdC10YDQs9C+0LjQvdGE0L4=?= =?UTF-8?B?0YDQvNCw0YbQuNC+0L3QvdC+0Lkg0LzQtdC00LjRhtC40L3Riywg0LHQuNC+?= =?UTF-8?B?0YTQuNC30LjQutC4LCDQutC+0LzQv9GM0Y7RgtC10YDQvdGL0YUg0YLQtdGF?= =?UTF-8?B?0L3QvtC70L7Qs9C40Lkg0Lgg0L/RgNC40L3RhtC40L/QvtCyINCy0L7RgdGC?= =?UTF-8?B?0L7Rh9C90L7QuSDQvNC10LTQuNGG0LjQvdGLIGh0dHBzOi8vYXl1cmRhcg==?= =?UTF-8?B?YS5ydS92b3Byb3Mtb3R2ZXQvc2VtaW5hcl9kb2t0?= =?UTF-8?B?b3JhX3N1YmlzaGFfc3VicmFtYW5pYW5hXzA5X2l5?= =?UTF-8?B?dWx5YV8yMDIy?= <subscribe@authorankurjain.com> Reply-To: jisankape@list.ru Subject: Newsletter Subcription Message-ID: <ae89ed411255e53e7eb7385d17d984ef@www.authorankurjain.com> X-Mailer: WPMailSMTP/Mailer/smtp 1.4.2 MIME-Version: 1.0 Content-Type: text/plain; charset=UTF-8 Content-Transfer-Encoding: 8bit Name: ШУГАРИНГ (Сахарная депиляция) Любая болезнь у разных людей проявляется по-разному https://ayurdara.ru/nashi_specialisty/psiholog_sergej_zagrebal_nyj/13/ Различия касаются не только ведущих симптомов болезни, но также, и даже в большей степени, таких деталей, как изменения настроения, жажда, аппетит, реакция на температуру и др https://ayurdara.ru/uslugi_i_ceny/medovo-tvorozhnyj_skrab/ Чтобы гомеопатическое лекарство сработало, оно должно подбираться с учётом всех этих индивидуальных проявлений https://ayurdara.ru/vopros-otvet/my_v_kontakte/ Поэтому не удивляйтесь, когда на приеме у гомеопата, Вам будет задано огромное количество вопросов, касающихся Ваших пристрастий, привычек и многого другого, что на первый взгляд кажется несущественным https://ayurdara.ru/fotoal_bomy/seminar_doktora_snehi_bhagvat_problemy_zhenskogo_zdorov_ya_i_puti_ih_estestvennogo_resheniya/_/ При этом сам прием продлится несколько дольше обычного https://ayurdara.ru/fotoal_bomy/goa/12/ Parivar — это семья https://ayurdara.ru/sredstva_firmy_kottakkal/sahacharadi_kashayam/ Акции на массажи и процедуры https://ayurdara.ru/fotoal_bomy/indijskij_tradicionnyj_centr_zdorov_ya_ayurdara/14/ Действие лекарств по принципу подобия тем, что гомеопатическое средство, вносимое в организм, вызывает там так называемую лекарственную болезнь, которая вытеснит из организма болезнь естественную, при условии, что лекарственная болезнь будет иметь достаточную силу https://ayurdara.ru/fotoal_bomy/den_jogi_2021/ Чем более подобными окажутся симптомы лекарственной болезни симптомам естественной, тем сильнее будет https://ayurdara.ru/ayurvedicheskie_preparaty_himalaya_herbals_indiya/kapikachhu_kapikachhu_himalaya/ Биорезонансная МОРА-терапия – новейшая разработка MED-TRONIK (Германия – лидер в создании приборов для биорезонансной терапии), включающая в себя синтез современных достижений энергоинформационной медицины, биофизики, компьютерных технологий и принципов восточной медицины https://ayurdara.ru/vopros-otvet/seminar_doktora_subisha_subramaniana_09_iyulya_2022/ Mobile: 84419827926 Email: jisankape@list.ru ----- This email was sent from a contact form on http://www.authorankurjain.com